Pharmaceutical giant Pfizer and German biotechnology company BioNTech have now started human testing in the U.S. for an experimental coronavirus vaccine.
The joint global vaccine development program is called BNT162.
The administration of doses to U.S. participants follows those given to participants in Germany last week.
Pfizer Chairman and CEO Albert Bourla has touted the program’s speedy progression from pre-clinical studies to human testing. It’s not the only potential COVID-19 vaccine program this far advanced.
In April, scientists at Britains Oxford University began testing a possible vaccine on humans.
Back in March, The National Institutes of Health became the first organization in the world to begin testing vaccines in humans.
- Coronavirus Timeline: State count for COVID-19 cases surpasses 25,000
- CHART: Tennessee Department of Health’s count of coronavirus cases by day in state
- 8-year-old North Carolina girl dies after battling COVID-19
- Tennessee issues new guidelines for concert venues, fairs and fireworks displays
- Coronavirus in Tennessee: Cases rise by 298 to 25,120 with 401 deaths
- Coronavirus in Tennessee: 112 active Knox County cases, 452 total
- East Tennessee healthcare worker shares experience treating COVID-19 patients in New York
- Delta Airlines to extend social distancing on flights through September
- Tennessee unemployment claims approaching 600,000 since mid-March
- White House fears resurgence of pandemic after protests
- City of Knoxville pools to reopen this weekend
- Coronavirus: Sevier County switching to appointment-only testing
- UPDATE: 13 test positive for COVID-19 at Maryville Newell plant
- Kids ask healthcare superheroes questions this weekend on ‘Coronavirus House Calls’
- Tennessee’s Lake County leads US in per capita virus cases